Skip to main content
SpringerLink
Log in

IgM-enriched Immunoglobulins in Sepsis

  • Conference paper
Intensive Care Medicine

Abstract

The role of intravenous immunoglobulins (IVIGs) as an adjunctive treatment in sepsis has been a subject of debate for years. The main critique has been the lack of randomized trials of adequate size showing the effect of IVIGs on outcome. For that reason, many of the guidelines on sepsis have not addressed the use of IVIG treatment. Likewise, the Surviving Sepsis Guidelines [1] did not consider the use of immunoglobulins in adult patients with sepsis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Dellinger RP, Carlet JM, Masur H, et al (2004) Surviving Sepsis Campaign Management Guidelines Committee. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 32: 858–873

    Article  PubMed  Google Scholar 

  2. Ziegler EJ, McCutchan JA, Fierer J, et al (1982) Treatment of Gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli. N Engl J Med 307: 1225–1230

    Article  CAS  PubMed  Google Scholar 

  3. Alejandria MM, Lansang MA, Dans LF, Mantaring JB (2002) Intravenous immunoglobulin for treating sepsis and septic shock. Cochrane Database Syst Rev CD0011090

    Google Scholar 

  4. Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35: 2677–2685

    Article  CAS  PubMed  Google Scholar 

  5. Norrby-Teglund A, Haque KN, Hammarström L (2006) Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis. J Intern Med 260: 509–516

    Article  CAS  PubMed  Google Scholar 

  6. Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35: 2686–2692

    Article  CAS  PubMed  Google Scholar 

  7. Pildal J, Gøtzsche PC(2004) Polyclonal immunoglobulin for treatment of bacterial sepsis: a systematic review. Clin Infect Dis 39: 38–46

    Article  CAS  PubMed  Google Scholar 

  8. Turgeon AF, Hutton B, Fergusson DA, et al (2007) Meta-analysis: intravenous immunoglobulin in critically ill adult patients with sepsis. Ann Intern Med 146: 193–203

    PubMed  Google Scholar 

  9. Werdan K, Pilz G, Bujdoso O, et al (2007) Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study. Crit Care Med 35: 2693–2701

    Article  CAS  PubMed  Google Scholar 

  10. Negi VS, Elluru S, Sibéril S, et al (2007) Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 27: 233–245

    Article  CAS  PubMed  Google Scholar 

  11. Werdan K (2001) Intravenous immunoglobulin for prophylaxis and therapy of sepsis. Curr Opin Crit Care 7: 354–361

    Article  CAS  PubMed  Google Scholar 

  12. Stephan W (1989) Investigations to demonstrate the antibacterial and antitoxic efficacy of an IgM-Enriched intravenous immunoglobulin preparation. In: Faist E, Ninnemann J, Green D (eds) Immune Consequences of Trauma; Shock and Sepsis. Springer-Verlag, Heidelberg, pp 501–507

    Google Scholar 

  13. Stephan W, Dichtelmüller H, Schedel I (1985) [Properties and efficacy of a human immunoglobulin M preparation for intravenous administration]. Arzneimittelforschung 35: 933–936

    CAS  PubMed  Google Scholar 

  14. Garbett ND, Matharu GS, Cole PJ (1989) Defective opsonization of Haemophilus influenzae by sera of elderly patients. Clin Exp Immunol 76: 73–75

    CAS  PubMed  Google Scholar 

  15. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR (1999) Immunoglobulin Menriched human intravenous immunoglobulin prevents complement activation in vitro an in vivo in a rat model of acute inflammation. Blood 93: 942–951

    CAS  PubMed  Google Scholar 

  16. Trautmann M, Held TK, Susa M, et al (1998) Bacterial lipopolysaccharide (LPS)-specific antibodies in commercial human immunoglobulin preparations: superior antibody content of an IgM-enriched product. Clin Exp Immunol 111: 81–90

    Article  CAS  PubMed  Google Scholar 

  17. Berger D, Schleich S, Seidelmann M, Berger HG (1993) Antiendotoxic therapy with polyclonal and polyvalent immunoglobulins: in vitro an in vivo studies. In: Faist E Meakins JL, Schildberg FW (eds) Host Defense Dysfunction in Trauma, Shock and Sepsis. Springer-Verlag, Heidelberg, pp 1164–1174

    Google Scholar 

  18. Norrby-Teglund A, Ihendyane N, Kansal R, et al (2000) Relative neutralizing activity in polyspecific IgM, IgA, and IgG preparations against group A streptococcal superantigens. Clin Infect Dis 31: 1175–1182

    Article  CAS  PubMed  Google Scholar 

  19. Oesser S, Schulze C, Seifert J (1999) Protective capacity of an IgM/IgA-enriched polyclonal immunoglobulin-G preparation in endotoxemia. Res Exp Med 198: 325–339

    Article  CAS  Google Scholar 

  20. Jacobs S, Sobki S, Morais C, Tariq M. (2000) Effect of pentaglobin and piperacillin on survival in a rat model of faecal peritonitis: importance of intervention timings. Acta Anaesthesiol Scand 44: 88–95

    Article  CAS  PubMed  Google Scholar 

  21. Hoffman JN, Fertmann JM, Vollmar B, Laschke MW, Jauch KW, Menger MD (2008) Immunoglobulin M-enriched human intravenous immunoglobulins reduce leukocyte-endothelial cell interactions and attenuate microvascular perfusion failure in normotensive endotoxemia. Shock 29: 133–139

    Article  PubMed  CAS  Google Scholar 

  22. Stehr SN, Knels L, Weissflog C, et al (2008) Effects of IGM-enriched solution on polymorphonuclear neutrophil function, bacterial clearance, and lung histology in endotoxemia. Shock 29: 167–172

    PubMed  Google Scholar 

  23. Lachmann RA, van Kaam AH, Haitsma JJ, Verbrugge SJ, Delreu F, Lachmann B (2004) Immunoglobulin M-enriched intravenous polyclonal immunoglobulins reduce bacteremia following Klebsiella pneumoniae infection in an acute respiratory distress syndrome rat model. Exp Lung Res 30: 251–260

    Article  CAS  PubMed  Google Scholar 

  24. Schedel I, Dreikhausen U, Nentwig B, et al (1991) Treatment of gram-negative septic shock with an immunoglobulin preparation: A prospective, randomized clinical trial. Crit Care Med 19: 1104–1113

    Article  CAS  PubMed  Google Scholar 

  25. Tugrul S, Ozcan PE, Akinci O, et al (2002) The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis. Crit Care 6: 357–362

    Article  PubMed  Google Scholar 

  26. Karatzas S, Boutzouka E, Venetsanou K, Myrianthefs P, Fildisis G, Baltopoulos G (2002) The effects of IgM-enriched immunoglobulin preparations in patients with severe sepsis: another point of view. Crit Care 6: 543–544

    Article  PubMed  Google Scholar 

  27. Rodríguez A, Rello J, Neira J, et al (2005) Effects of high-dose of intravenous immunoglobulin and antibiotics on survival for severe sepsis undergoing surgery. Shock 23: 298–304

    Article  PubMed  CAS  Google Scholar 

  28. Hentrich M, Fehnle K, Ostermann H, et al (2006) IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiplecenter trial. Crit Care Med 34: 1319–1325

    Article  CAS  PubMed  Google Scholar 

  29. Werdan K, Pilz G, Müller-Werdan U, et al (2008) Immunoglobulin G treatment of postcardiac surgery patients with score-identified severe systemic inflammatory response syndrome—the ESSICS study. Crit Care Med 36: 716–723

    Article  CAS  PubMed  Google Scholar 

  30. Pilz G, Kreuzer E, Kaab S, Appel R, Werdan K (1994) Early sepsis treatment with immunoglobulins after cardiac surgery in score-identified high-risk patients. Chest 105: 76–82

    Article  CAS  PubMed  Google Scholar 

  31. Pilz G, Appel R, Kreuzer E, Werdan K (1997) Comparison of early IgM-enriched immunoglobulin vs polyvalent IgG administration in score-identified postcardiac surgical patients at high risk for sepsis. Chest 111: 419–426

    Article  CAS  PubMed  Google Scholar 

  32. Buda S, Riefolo A, Biscione R, et al (2005) Clinical experience with polyclonal IgM-enriched Immunoglobulins in a group of patients affected by sepsis after cardiac surgery. J Cardiothorac Vasc Anesth 19: 440–445

    Article  CAS  PubMed  Google Scholar 

  33. Kress HG, Scheidewing C, Schmidt H, Silber R (1999) Reduced incidence of postoperative infection after intravenous administration of an immunoglobulin A-and immunoglobulin M-enriched preparation in anergic patients undergoing cardiac surgery. Crit Care Med 27: 1281–1287

    Article  CAS  PubMed  Google Scholar 

  34. Haque K, Remo C, Bahakim H (1995) Comparison of two types of intravenous immunoglobulins in the treatment of neonatal sepsis. Clin Exp Immunol 101: 328–333

    CAS  PubMed  Google Scholar 

  35. Mohr M, Englisch L, Roth A, Burchardi H, Zielmann S (1997) Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 23: 1144–1149

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesiology and Intensive Care Medical Faculty of Istanbul, University of Istanbul, Capa Klinikleri, 34093, Istanbul, Turkey

    F. Esen & S. Tugrul

Authors
  1. F. Esen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Tugrul
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Intensive Care Erasme Hospital, Universitée libre de Bruxelles, Route de Lennik 808, B-1070, Brussels, Belgium

    Jean-Louis Vincent (Head) (Head)

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Esen, F., Tugrul, S. (2009). IgM-enriched Immunoglobulins in Sepsis. In: Vincent, JL. (eds) Intensive Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-92278-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-92278-2_10

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-92277-5

  • Online ISBN: 978-0-387-92278-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation